This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's What Could Help Griffon (GFF) Maintain Its Recent Price Strength
by Zacks Equity Research
Griffon (GFF) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
3M (MMM) Stock Declines 18% YTD: What's Pulling it Down?
by Zacks Equity Research
3M (MMM) grapples with supply-chain constraints and foreign-currency headwinds. Decline in disposable respirator sales is an added concern for the company.
Fast-paced Momentum Stock Griffon (GFF) Is Still Trading at a Bargain
by Zacks Equity Research
Griffon (GFF) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Wall Street Analysts Think Griffon (GFF) Could Surge 34%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 33.8% upside potential for Griffon (GFF). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Has Carlisle Companies (CSL) Outpaced Other Conglomerates Stocks This Year?
by Zacks Equity Research
Here is how Carlisle (CSL) and Griffon (GFF) have performed compared to their sector so far this year.
Griffon (GFF) Is a Great Choice for "Trend" Investors, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Griffon (GFF) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
How Much Upside is Left in Griffon (GFF)? Wall Street Analysts Think 38%
by Zacks Equity Research
The consensus price target hints at a 37.7% upside potential for Griffon (GFF). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Carlisle (CSL) Q2 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Carlisle's (CSL) Q2 earnings results reflect gains from solid performances across all its segments.
Flowserve (FLS) Beats on Q2 Earnings, Revenues Slip Y/Y
by Zacks Equity Research
Flowserve's (FLS) Q2 performance benefits from higher bookings and backlog levels, partly hurt by supply-chain woes and inflationary pressure.
Graco (GGG) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Graco's (GGG) Q2 performance benefit from solid performances at the Industrial and Process segments owing to volume growth and effective pricing.
Are Conglomerates Stocks Lagging Carlisle Companies (CSL) This Year?
by Zacks Equity Research
Here is how Carlisle (CSL) and Griffon (GFF) have performed compared to their sector so far this year.
Honeywell's (HON) Q2 Earnings & Revenues Beat, Increase Y/Y
by Zacks Equity Research
Honeywell's (HON) Q2 results benefit from growth in commercial aerospace, building products, advanced sensing technologies and advanced materials businesses. The company improves its 2022 guidance.
A. O. Smith's (AOS) Q2 Earnings Beat, Revenues Miss Mark
by Zacks Equity Research
A. O. Smith's (AOS) Q2 results benefit from higher sales in North America and India. However, the company reduces sales forecast for 2022 due to lower volumes in water heating business.
Honeywell International Inc. (HON) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Honeywell International Inc. (HON) delivered earnings and revenue surprises of 3.45% and 3.06%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
General Electric (GE) Q2 Earnings & Revenues Top, Increase Y/Y
by Zacks Equity Research
General Electric's (GE) second-quarter 2022 revenues increase 2% year over year, driven by an impressive performance across its Healthcare and Aerospace segments.
3M's (MMM) Q2 Earnings & Revenues Beat Estimates, Decline Y/Y
by Zacks Equity Research
3M's (MMM) Q2 results are hurt by foreign-currency headwinds. The company lowers its 2022 adjusted earnings guidance on the same ground.
Roper (ROP) Beats on Q2 Earnings, Improves 2022 Outlook
by Zacks Equity Research
Roper's (ROP) Q2 results benefit from software recurring revenue growth. Owing to strong performance, the company raises its full-year earnings guidance.
Danaher's (DHR) Q2 Earnings & Revenues Beat, Increase Y/Y
by Zacks Equity Research
Danaher's (DHR) second-quarter 2022 revenues increase 7.4% year over year, driven by an impressive performance across its segments.
Zacks Industry Outlook Highlights Carlisle Companies, Griffon and Star Equity Holdings
by Zacks Equity Research
Carlisle Companies, Griffon and Star Equity Holdings are part of Zacks Industry Outlook article.
General Electric (GE) Arm Wins Power Plant Deal in Poland
by Zacks Equity Research
The combined cycle power plant will consist of General Electric's (GE) 9HA.02 gas turbine. When completed, the power plant will be able to produce electricity of 745 megawatts.
3 Stocks to Buy From the Prospering Diversified Operations Industry
by Eshani Haque
Growth in manufacturing activities and strong demand across various end markets favor the Zacks Diversified Operations industry's prospects. CSL, GFF and STRR are poised to take advantage of the buoyant scenario.
Find Strong Stocks to Buy in the Second Half with this ROE Screen
by Benjamin Rains
Investors looking to add stocks in the second half should consider buying companies that have proven they can turn assets into profits amid the unknowns and recession fears.
3M (MMM) to Divest Neoplast & Neobun Brands to Selic Corp
by Zacks Equity Research
3M's (MMM) portfolio restructuring actions are expected to help the company focus on its core business areas and drive growth.
ITT's Abundant Prospects a Boon, Persistent Risks a Bane
by Zacks Equity Research
ITT is poised to benefit from a solid momentum across its end markets, acquisition and growth investments. Rising costs and expenses, and forex woes might affect its performance.
Here's Why You Can Consider Investing in Carlisle (CSL) Stock
by Zacks Equity Research
Carlisle (CSL) stands to benefit from strength across its businesses, acquired assets and shareholder-friendly policies.